Southampton scientists reveal a new fundamental feature of resistance to therapy in aggressive chronic lymphocytic leukaemia

Research led by the Centre for Cancer Immunology could help identify patients at risk of rapid progression and resistance to therapy in chronic lymphocytic leukaemia (CLL).